DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

In May 2024, the Tandem Mobi insulin pump with Control-IQ technology completed integration with both Dexcom G7 and Dexcom G6 CGM Systems. With this, Tandem Diabetes became the only company that ...

2024--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) today announced the updated t:slim X2™ insulin pump software is compatible with both Dexcom G7 and Dexcom G6 ...

Dexcom and Tandem Diabetes Care (NASDAQ:TNDM) announced that the t:slim X2 insulin pump software now supports both Dexcom G7 and G6 Continuous Glucose Monitoring Systems. This advancement marks ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at an ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at ...

The FDA announced on Monday that it has cleared Insulet’s Omnipod insulin pump as the first ... made by both Abbott and Dexcom — which is something that Tandem has done as well.